Xu’s team found that EPAS1 gene is dysregulated in non–small cell lung cancer, which encodes hypoxia-inducible factor 2α and plays an important role in the progression of non–small cell lung cancer (Xu et al., 2018). The gene discussed is EPAS1; the disease is lung cancer.